Rk. Kharbanda et al., Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo, CIRCULATION, 103(12), 2001, pp. 1624-1630
Citations number
22
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-Endothelial dysfunction leading to neutrophil infiltration of ti
ssues has been implicated in tissue injury caused by ischemia-reperfusion (
IR). Tissue injury during IR can be reduced by prior ischemic preconditioni
ng (IPC). In humans, it is unclear whether endothelial dysfunction occurs d
uring IR or whether IPC offers protection against endothelial dysfunction a
nd inflammatory cell activation. We studied the effects of experimental IR
on endothelial and neutrophil function in the human forearm in vivo and exa
mined the protection afforded by IPC.
Method and Results-The forearm was made ischemic for 20 minutes by inflatin
g a blood pressure cuff to 200 mm Hg. We assessed endothelial function of c
onduit (radial artery flow-mediated dilation) and resistance vessels (blood
flow responses to intra-arterial infusion of the endothelium-dependent dil
ator acetylcholine) in healthy volunteers before and after IR, IR reduced f
low-mediated dilation of the radial artery at 15 minutes of reperfusion (7.
7 +/-1.5% to 3.5 +/-0.9%) and the dilator response of resistance vessels to
acetylcholine at 15, 30, and 60 minutes of reperfusion, IR did not reduce
the dilator response of the radial artery to glyceryltrinitrate and only ca
used a small reduction of glyceryltrinitrate-induced dilation of resistance
vessels at 60 minutes of reperfusion, IR caused an increase in neutrophil
CD11b expression and platelet-neutrophil complexes in the circulating blood
. IPC (three 5-minute episodes of ischemia) before IR prevented endothelial
dysfunction and neutrophil activation.
Conclusions-A clinically relevant period of ischemia-reperfusion causes pro
found and sustained endothelial dysfunction and systemic neutrophil activat
ion. IPC attenuates both of these effects in humans.